Establishment and Characterization of a New Ph¹-Positive Chronic Myeloid Leukemia Cell Line MC3 with Trilineage Phenotype and an Altered p53 Gene

References

• Heisterkamp N., Stephen J.R., Groffen J., Hanesen P.F., deKlein A., Bartrum C.R., Grosveld G. Localization of the c-abl oncogene adjacent to a translocation breakpoint in chronic myelogenous leukemia. Nature 1983; 306: 239–242
   PubMed Web of Science ®Google Scholar
• Groffen J., Stephenson J.R., Heisterkamp N., Deklein A., Bartram C.R., Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, ber, on chromosome 22. Cell 1984; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Konopka J.B., Watanabe S.M., Witte O.N. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell. 1984; 37: 1035–1042
   PubMed Web of Science ®Google Scholar
• Daley G.O., Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210ber/abl protein. Proc. Nail. Acad. Sci. USA 1988; 85: 9312–9316
   PubMed Web of Science ®Google Scholar
• Daley G.Q., Van Etten R.A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210ber/abl gene of the Philadelphia chromosome. Science 1991; 247: 824–830
   Web of Science ®Google Scholar
• Pendergast A.M., Muller A.J., Havlik M.H., Maru Y., Witte O.N. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 1991; 66: 161–171
   PubMed Web of Science ®Google Scholar
• Bernstein R. Cytogenetics of chronic myelogenous leukemia. Semin. HematoL 1988; 25: 20–34
   PubMed Web of Science ®Google Scholar
• Collins S.J., Groudine M.T. Chronic myelogenous leukemia: Amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis. Blood 1987; 69: 893–898
   PubMed Web of Science ®Google Scholar
• Okabe M., Matsushima S. Philadelphia chromosome-positive leukemia: Molecular analysis of ber and abl genes and transforming genes. Acta Haematol. Japonica 1988; 51: 1471–1480
   PubMed Web of Science ®Google Scholar
• Liu E., Hjelle B., Bishop J.M. Transforming genes in chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 1988; 85: 1952–1956
   PubMed Web of Science ®Google Scholar
• Collins S.J., Howard M., Andrew D.F., Agura E., Radich J. Rare occurrence of N-ras point mutation in Philadelphia chromosome positive chronic myeloid leukemia. Blood 1989; 73: 1028–1032
   PubMed Web of Science ®Google Scholar
• Ahuja H., Bar-Eli M., Arlin Z., Advani S., Allen S.L., Goldman J., Snyder D., Foti A., Cline A. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J. Clin. Invest. 1991; 87: 2042–2047
   PubMed Web of Science ®Google Scholar
• Okabe M., Kunieda Y., Miyazaki T. Blast crisis accompanied with occurrence of the point-mutational activation of N-ras protooncogene and the chromosomal abnormality inv(3q) in chronic myelogenous leukemia presenting thrombocytosis. Leukemia 1990; 4: 381–382
   PubMed Web of Science ®Google Scholar
• Okabe M., Kunieda Y., Sugiura T., Tanaka M., Miyag-Ishima T., Saiki I., Minagawa T., Kurosawa M., Itaya T., Miyazaki T. Inhibitory effect of interleukin-4 on in vitro growth of Ph'-positive acute lymphoblastic leukemia. Blood. 1991; 78: 1574–1580
   PubMed Web of Science ®Google Scholar
• Okabe M., Uehara Y., Miyagishima T., Itaya T., Tanaka M., Kunieda Y., Kurosawa M., Miyazaki T. Effect of he herbimycin A, an antagonist of tyrosine kinase, on ber/abl/ oncoprotein-associated cell proliferations: Abrogative effect on the transformation of murine hematopoietic cells by transfection of a retroviral vector expressing oncoprotein P210ber/abl and preferential inhibition on Ph1-positive leukemia cell growth. Blood 1992; 80: 1330–1338
   PubMed Web of Science ®Google Scholar
• Okabe M., Matsushima S., Morioka M., Kobayashi M., Abe S., Sakurada K., Kakinuma M., Miyazaki T. Establishment and characterization of a cell line, TOM-1, derived from a patient with Philadelphia chromosome-positive acute lymphocytic leukemia. Blood 1987; 69: 990–998
   PubMed Web of Science ®Google Scholar
• Ahuja H., Bar-Eli M., Advani S.H., Benchimol S., Cline M. Alteration in the p53 gene and the clonal evolution of the blast crisis of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 1989; 86: 6783–6787
   PubMed Web of Science ®Google Scholar
• Okabe M., Oita M., Kunieda Y., Tatsuura J., Sakurada K., Matsushima S., Kakinuma M., Miyazaki T. ber Rearrangement and c-abl expression in Ph-positive hybrid leukemia with simultaneous proliferation of lymphoid and myeloid blasts. Blut 1989; 58: 241–246
   PubMedGoogle Scholar
• Higa T., Okabe M., Kunieda Y., Kodama S., Itaya T., Kurosawa M., Sakurada K., Maekawa I., Shoji M., Kasai M., Miyazaki T. Establishment and characterization of a new Ph1-positive ALL cell line (ALL/MIK) presenting ber rearrangement on ber-2 and ALL-type ber/abl transcript: Suggestion of in vitro differentiation to monocytoid lineage. Leukemia and Lymphoma 1994; 12: 287–296
   PubMed Web of Science ®Google Scholar
• Okabe M., Kunieda Y., Miyagishim T., Kobayashi M., Kurosawa M., Itaya T., Sakurada K., Miyazaki T. BCR/ABL oncoprotein-targeted antitumor activity of antisense oligodeoxynucleotides complementary to bcr/abl mRNA and hebimycin A., an antagonist of protein tyrosine kinase: Inhibitory effects on in vitro growth of Ph1-positive leukemia cells and BCR/ABL oncoprotein-associated transformed cells. Leukemia and Lymphoma 1993; 10: 307–316
   PubMed Web of Science ®Google Scholar
• Okabe M., Kawamura K., Miyagishima T., Itaya T., Goodwyn D., Shoji M., Vogler W.R., Sakurada K., Uehara M., Miyazaki T. Effect of herbimycin A., an inhibitor of tyrosine kinase, on protein tyrosine activity and phosphotyrosy1 proteins of Ph1-positive leukemia cells. Leuk. Res. 1994; 18: 213–220
   PubMed Web of Science ®Google Scholar
• Griffin J.D., Todd R.F., III, Ritz J., Nadler L.M., Canellos G.P., Rosenthal D., Gallivan M., Beveridge R.P., Weinstein H., Karp D., Schlossman S.F. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood 1983; 61: 85–91
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Immamura M., Gotohda Y., Maeda S., Iwasaki H., Sakurada K., Kasai M., Hapel A.J., Miyazaki T. Synergistic effects of interleukin-1 and in-terleukin-3 on the expansion of human hematopoietic progenitor cells in liquid cultures. Blood 1991; 78: 1947–1953
   PubMed Web of Science ®Google Scholar
• Fourth International Workshop on Chromosomes in Leukemia. A Prospective Study of Acute Nonlymphocytic Leukemia: Abnormalities of chromosome 3 among 24 patients with ANLL. Cancer Genet. Cytogenet. 1984; 11: 306
   Google Scholar
• Carroll A.J., Poon M.-C, Robinson N.C., Crist W.M. Sideroblastic anemia associated with thrombocytosis and a chromosome 3 abnormality. Cancer Genet. Cytogenet. 1986; 22: 183–187
   PubMed Web of Science ®Google Scholar
• Sweet D.L., Golomb H.M., Rowley J.D., Vardiman J.M. Acute myelogenous leukemia and thrombocytosis associated with an abnormality of chromosome No. 3. Cancer Genet. Cytogenet. 1979; 1: 33–37
   Web of Science ®Google Scholar
• Carbonell F., Hoelzer D., Thiel E., Bartl R. Ph1-positive CML associated with megakaryocyte hyperplasia and thrombocythemia and an abnormality of chromosome No. 3. Cancer Genet. Cytogenet. 1982; 6: 153–161
   PubMed Web of Science ®Google Scholar
• Bitter M.A., Neilly M.E., LeBeau M.M., Pearson M.G., Rowley J.D. Rearrangement of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood 1985; 66: 1362–1370
   PubMed Web of Science ®Google Scholar
• Bernstein R., Pinto M., Lewis D., Mendelow B. Chromosome 3q21 abnormalities associated with hyperactive thrombopoiesis in acute blastic transformation of chronic myeloid leukemia. Blood. 1986; 68: 652–657
   PubMed Web of Science ®Google Scholar
• Aaronson S.A. Growth factors and cancer. Science 1991; 254: 1146–1153
   PubMed Web of Science ®Google Scholar
• Farr C.J., Saiki R.K., Erlich H.A., McCormick F., Marshall C.J. Analysis of ras gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc. Natl. Acad. Sci. USA 1988; 85: 1629–1633
   PubMed Web of Science ®Google Scholar
• Shen W.P.V., Aldrich T.H., Venta-Perez G., Franza B.R., Furth M.E. Expression of normal and mutant ras proteins in human leukemia. Oncogene 1987; 1: 157–165
   PubMed Web of Science ®Google Scholar
• Toksoz D., Farr C.J., Marshall C.J. RAS genes and acute myeloid leukemia. Br. J. Haematol. 1989; 71: 1–6
   PubMed Web of Science ®Google Scholar